| Pulmonary fibrosis in the aftermath of the COVID-19 era E Vasarmidi, E Tsitoura, DA Spandidos, N Tzanakis, KM Antoniou Experimental and therapeutic medicine 20 (3), 2557-2560, 2020 | 214 | 2020 |
| European Respiratory Society statement on long COVID follow-up KM Antoniou, E Vasarmidi, AM Russell, C Andrejak, B Crestani, ... European Respiratory Journal 60 (2), 2022 | 119 | 2022 |
| NLRP3 inflammasome expression in idiopathic pulmonary fibrosis and rheumatoid lung I Lasithiotaki, I Giannarakis, E Tsitoura, KD Samara, GA Margaritopoulos, ... European Respiratory Journal 47 (3), 910-918, 2016 | 96 | 2016 |
| Pirfenidone in the treatment of idiopathic pulmonary fibrosis: an evidence-based review of its place in therapy GA Margaritopoulos, E Vasarmidi, KM Antoniou Core evidence, 11-22, 2016 | 90 | 2016 |
| Smoking and interstitial lung diseases GA Margaritopoulos, E Vasarmidi, J Jacob, AU Wells, KM Antoniou European Respiratory Review 24 (137), 428-435, 2015 | 88 | 2015 |
| Pirfenidone improves survival in IPF: results from a real-life study GA Margaritopoulos, A Trachalaki, AU Wells, E Vasarmidi, E Bibaki, ... BMC pulmonary medicine 18, 1-7, 2018 | 85 | 2018 |
| Efficacy and safety of nintedanib in a Greek multicentre idiopathic pulmonary fibrosis registry: a retrospective, observational, cohort study K Antoniou, K Markopoulou, A Tzouvelekis, A Trachalaki, E Vasarmidi, ... ERJ open research 6 (1), 2020 | 50 | 2020 |
| Increased monocyte count and red cell distribution width as prognostic biomarkers in patients with Idiopathic Pulmonary Fibrosis T Karampitsakos, S Torrisi, K Antoniou, E Manali, I Korbila, ... Respiratory research 22 (1), 140, 2021 | 47 | 2021 |
| Enhanced IL-1β release following NLRP3 and AIM2 inflammasome stimulation is linked to mtROS in airway macrophages in pulmonary fibrosis A Trachalaki, E Tsitoura, S Mastrodimou, R Invernizzi, E Vasarmidi, ... Frontiers in immunology 12, 661811, 2021 | 44 | 2021 |
| Accumulation of damaged mitochondria in alveolar macrophages with reduced OXPHOS related gene expression in IPF E Tsitoura, E Vasarmidi, E Bibaki, A Trachalaki, C Koutoulaki, ... Respiratory research 20, 1-16, 2019 | 41 | 2019 |
| miR-185 and miR-29a are similarly expressed in the bronchoalveolar lavage cells in IPF and lung cancer but common targets DNMT1 and COL1A1 show disease specific patterns E Bibaki, E Tsitoura, E Vasarmidi, G Margaritopoulos, A Trachalaki, ... Molecular medicine reports 17 (5), 7105-7112, 2018 | 32 | 2018 |
| Epidemiology of interstitial lung diseases and their progressive-fibrosing behaviour in six European countries O Hilberg, AM Hoffmann-Vold, V Smith, D Bouros, M Kilpeläinen, J Guiot, ... ERJ open research 8 (1), 2022 | 28 | 2022 |
| MiR-185/AKT and miR-29a/collagen 1a pathways are activated in IPF BAL cells E Tsitoura, AU Wells, K Karagiannis, I Lasithiotaki, E Vasarmidi, E Bibaki, ... Oncotarget 7 (46), 74569, 2016 | 28 | 2016 |
| Orphan lung diseases: a clinical guide to rare lung disease V Cottin, L Richeldi, K Brown, FX McCormack Springer Nature, 2023 | 19 | 2023 |
| Collagen 1a1 expression by airway macrophages increases in fibrotic ILDs and is associated with FVC decline and increased mortality E Tsitoura, A Trachalaki, E Vasarmidi, S Mastrodemou, ... Frontiers in immunology 12, 645548, 2021 | 19 | 2021 |
| COVID19 alert Do we know our enemy? K Antoniou, M Bolaki, E Bibaki, E Vasarmidi, A Trachalaki, E Tsitoura, ... Pneumon 33 (1), 2020 | 16 | 2020 |
| Investigation of key autophagy-and mitophagy-related proteins and gene expression in BALF cells from patients with IPF and RA-ILD E Vasarmidi, S Sarantoulaki, A Trachalaki, G Margaritopoulos, E Bibaki, ... Molecular Medicine Reports 18 (4), 3891-3897, 2018 | 14 | 2018 |
| Early COVID-19 lockdown in Greece and idiopathic pulmonary fibrosis: a beneficial “impact” beyond any expectation SA Papiris, D Bouros, K Markopoulou, L Kolilekas, AI Papaioannou, ... European Respiratory Journal 57 (3), 2021 | 13 | 2021 |
| Detection of mitochondrial transfer RNA (mt-tRNA) gene mutations in patients with idiopathic pulmonary fibrosis and sarcoidosis Z Daniil, OS Kotsiou, A Grammatikopoulos, S Peletidou, H Gkika, F Malli, ... Mitochondrion 43, 43-52, 2018 | 12 | 2018 |
| FGF19 is downregulated in idiopathic pulmonary fibrosis and inhibits lung fibrosis in mice A Justet, M Ghanem, T Boghanim, M Hachem, E Vasarmidi, M Jaillet, ... American Journal of Respiratory Cell and Molecular Biology 67 (2), 173-187, 2022 | 11 | 2022 |
